Localised | Regional | Distant | Unknown | All stages | ||
---|---|---|---|---|---|---|
Characteristics | Per cent within categories | n | (%)* | |||
Year of diagnosis | ||||||
2001–2005 | 48.1 | 5.8 | 4.1 | 42.0 | 23 885 | (47.2) |
2006–2009 | 51.8 | 6.9 | 3.3 | 38.0 | 26 712 | (52.8) |
Age at diagnosis | ||||||
Median age (years) | 66 | 65 | 77 | 72 | 68 | |
18–64 | 61.1 | 8.7 | 1.7 | 28.5 | 17 490 | (34.6) |
65–74 | 49.7 | 6.6 | 2.6 | 41.0 | 18 656 | (36.9) |
75–99 | 37.0 | 3.3 | 7.6 | 52.1 | 14 451 | (28.6) |
Country of birth | ||||||
Australia | 50.7 | 6.5 | 3.7 | 39.1 | 36 090 | (71.3) |
High English proficiency countries | 52.7 | 7.3 | 3.8 | 36.2 | 5300 | (10.5) |
Moderate English proficiency countries | 52.1 | 6.0 | 3.5 | 38.5 | 2998 | (5.9) |
Low English proficiency countries | 47.8 | 5.7 | 4.5 | 42.0 | 5430 | (10.7) |
Unknown | 8.5 | 1.5 | 0.6 | 89.3 | 779 | (1.5) |
Geographical location† | ||||||
Major cities | 50.9 | 6.6 | 3.8 | 38.7 | 33 509 | (66.2) |
Inner regional | 48.6 | 5.8 | 3.7 | 41.9 | 12 916 | (25.5) |
Rural | 47.8 | 6.2 | 3.4 | 42.5 | 4172 | (8.2) |
Socioeconomic status† | ||||||
Least disadvantaged | 57.8 | 8.3 | 2.7 | 31.1 | 12 695 | (25.1) |
Middle group | 48.0 | 6.0 | 4.1 | 42.0 | 24 213 | (47.9) |
Most disadvantaged | 46.5 | 5.3 | 4.1 | 44.2 | 13 689 | (27.1) |
Lived near state borders | ||||||
No | 50.6 | 6.5 | 3.7 | 39.2 | 46 312 | (91.5) |
Yes | 44.5 | 5.4 | 3.5 | 46.7 | 4285 | (8.5) |
Cases linked with APDC | ||||||
No | 24.1 | 3.3 | 1.5 | 71.1 | 1840 | (3.6) |
Yes | 51.0 | 6.5 | 3.8 | 38.7 | 48 757 | (96.4) |
Comorbidity score‡ | ||||||
No record in time range | 19.3 | 2.4 | 1.4 | 76.9 | 9027 | (17.8) |
None | 57.8 | 7.5 | 3.5 | 31.2 | 36 826 | (72.8) |
1+ | 48.0 | 5.6 | 9.6 | 36.8 | 4744 | (9.4) |
Total | 50.0 | 6.4 | 3.7 | 39.9 | 50 597 | (100) |
*Percentage within total.
†Geographical location and socioeconomic status were based on the men's place of residence at diagnosis.
‡Diseases in the Charlson comorbidity index excluding prostate cancer and metastases within 6 months before and 6 months after diagnosis.